In Europe, 50,000 new cases of glioma occur each year, and this number is expected to rise with the ageing population. Well-established international consortia are putting tremendous research efforts into a better understanding of glioma pathology and improved treatment strategies. Magnetic resonance imaging (MRI) only has a minor role in these research efforts, despite being a widely available medical imaging modality and whilst advanced MRI techniques are emerging with great potential for improved characterisation of glioma.
The Core Leadership consists of the Action Chair, Vice-Chair, Working Group Leaders and Vice-Leaders, the Science Communication Officers, the Short Term Scientific Mission Coordinator, and the ITC Conference Grant Coordinator. During the first Management Committee meeting in September 2019 it was decided that this group has a mandate to decide on the distribution of the funds for the Short Term Scientific Missions and the ITC Conference Grants. Additionally, the Core Leadership has regular teleconferences to keep up with the deliverables of the Action. Do you have anything you would like to share with the Core Leadership or do you have any questions for either of them? Do not hesitate to get in touch.
A full list of participants can be found here. As a participant of GliMR you can attend the networking events hosted by our Action. Additionally, you will be kept up to date via our regular newsletter and newsflashes. If you would like to become a participant, do not hesitate to get in touch.
Here you can find an overview of the Management Committee Members and Substitutes.
An overview of all stakeholders of GliMR can be found here.